Rossari Biotech Limited (NSE:ROSSARI)

Rossari Biotech Statistics

Total Valuation

Rossari Biotech has a market cap or net worth of INR 34.23 billion. The enterprise value is 35.23 billion.

Market Cap	34.23B
Enterprise Value	35.23B

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	Jun 20, 2025

Share Statistics

Rossari Biotech has 55.37 million shares outstanding. The number of shares has increased by 0.07% in one year.

Current Share Class	55.37M
Shares Outstanding	55.37M
Shares Change (YoY)	+0.07%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	64.54%
Owned by Institutions (%)	22.49%
Float	16.51M

Valuation Ratios

The trailing PE ratio is 25.34 and the forward PE ratio is 20.16. Rossari Biotech's PEG ratio is 1.12.

PE Ratio	25.34
Forward PE	20.16
PS Ratio	1.60
PB Ratio	2.89
P/TBV Ratio	3.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.12

Enterprise Valuation

EV / Earnings	26.08
EV / Sales	1.65
EV / EBITDA	13.72
EV / EBIT	18.63
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.18
Debt / EBITDA	0.85
Debt / FCF	n/a
Interest Coverage	9.46

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.13%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	39.89M
Profits Per Employee	2.52M
Employee Count	535
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Rossari Biotech has paid 492.22 million in taxes.

Income Tax	492.22M
Effective Tax Rate	26.71%

Stock Price Statistics

The stock price has decreased by -31.28% in the last 52 weeks. The beta is 0.27, so Rossari Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-31.28%
50-Day Moving Average	677.74
200-Day Moving Average	705.57
Relative Strength Index (RSI)	29.97
Average Volume (20 Days)	46,648

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rossari Biotech had revenue of INR 21.34 billion and earned 1.35 billion in profits. Earnings per share was 24.39.

Revenue	21.34B
Gross Profit	6.65B
Operating Income	1.88B
Pretax Income	1.84B
Net Income	1.35B
EBITDA	2.50B
EBIT	1.88B
Earnings Per Share (EPS)	24.39

Balance Sheet

The company has 1.17 billion in cash and 2.18 billion in debt, giving a net cash position of -1.01 billion or -18.18 per share.

Cash & Cash Equivalents	1.17B
Total Debt	2.18B
Net Cash	-1.01B
Net Cash Per Share	-18.18
Equity (Book Value)	11.85B
Book Value Per Share	214.12
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 31.14%, with operating and profit margins of 8.80% and 6.33%.

Gross Margin	31.14%
Operating Margin	8.80%
Pretax Margin	8.63%
Profit Margin	6.33%
EBITDA Margin	11.70%
EBIT Margin	8.80%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.08%.

Dividend Per Share	0.50
Dividend Yield	0.08%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.07%
Shareholder Yield	0.01%
Earnings Yield	3.95%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2